AI assistant
Sending…
Cardlytics, Inc. — Director's Dealing 2018
Feb 9, 2018
33956_dirs_2018-02-08_6b98b712-900a-472c-bf1a-2e87ff612d78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2018-02-08
Reporting Person: BANK OF AMERICA CORP /DE/ (10% Owner)
Reporting Person: Banc of America Strategic Investments CORP (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrant (right to buy) | $2.52 | 2021-03-03 | Common Stock (78100.5) | Indirect | |
| Warrant (right to buy) | $6.52 | 2021-03-03 | Common Stock (312402) | Indirect |
Footnotes
F1: The warrant is fully vested and exercisable.
F2: Represents a warrant to purchase shares held directly by Banc of America Strategic Investments Corporation ("BASIC"), a wholly owned subsidiary of Bank of America Corporation ("BAC"). Each of BAC and BASIC expressly disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.
More from Cardlytics, Inc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Jan 26